![]() The biosimilars included in Alberta’s Biosimilars Initiative are approved by Health Canada. These variations are not clinically meaningful. Alberta Blue Cross health professionals’ resourcesīiologics are drugs manufactured in, extracted from, or semi-synthesized from living cells through a highly complex manufacturing process.Ī biosimilar is highly similar to the first biologic drug that was authorized for sale called an 'originator biologic.' Due to the complexity of biologic drugs and the natural variability that results from using living cells, it is not possible for a biosimilar to be identical to its originator biologic drug, nor is it possible for different lots or 'batches' of an originator biologic drug to be identical.Alberta Blue Cross biosimilar initiative patient information.If you are unable to switch to the biosimilar version for medical reasons, your health care professional can help determine whether to request exceptional coverage of the originator biologic. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |